Metabolomic Profiling of Leukemic Hematopoiesis: Effects of BNT162b2 mRNA COVID-19 Vaccine Administration.

Erdogdu B, Kaplan O, Fidan BB, Celebier M, Malkan UY, Haznedaroglu IC.

Open source

DOI
10.2174/0115665240361878250601074746
Published
2026-01-01
Container
Curr Mol Med
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0115665240361878250601074746,
  title = {Metabolomic Profiling of Leukemic Hematopoiesis: Effects of BNT162b2 mRNA COVID-19 Vaccine Administration.},
  author = {Erdogdu B and  Kaplan O and  Fidan BB and  Celebier M and  Malkan UY and  Haznedaroglu IC.},
  year = {2026},
  journal = {Curr Mol Med},
  doi = {10.2174/0115665240361878250601074746},
  url = {https://doi.org/10.2174/0115665240361878250601074746}
}

RIS

TY  - JOUR
TI  - Metabolomic Profiling of Leukemic Hematopoiesis: Effects of BNT162b2 mRNA COVID-19 Vaccine Administration.
AU  - Erdogdu B
AU  -  Kaplan O
AU  -  Fidan BB
AU  -  Celebier M
AU  -  Malkan UY
AU  -  Haznedaroglu IC.
PY  - 2026
JO  - Curr Mol Med
DO  - 10.2174/0115665240361878250601074746
UR  - https://doi.org/10.2174/0115665240361878250601074746
ER  - 

APA

B, E., O, K., BB, F., M, C., UY, M., & IC., H. (2026). Metabolomic Profiling of Leukemic Hematopoiesis: Effects of BNT162b2 mRNA COVID-19 Vaccine Administration.. Curr Mol Med. https://doi.org/10.2174/0115665240361878250601074746

Source records